Sprott Inc’s Maravai LifeSciences MRVI Stock Holding History

Sprott Inc’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$62.4K	Hold	10,000	–	–	﹤0.01%	257
2026 Q1	$28.3K	Hold	10,000	–	–	﹤0.01%	235
2025 Q4	$32.5K	Hold	10,000	–	–	﹤0.01%	211
2025 Q3	$28.7K	Buy	+10,000	New	+$25.5K	﹤0.01%	205

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Sprott Inc's MRVI Position: Q2 2026 in Review

Sprott Inc held its Maravai LifeSciences (MRVI) position steady in Q2 2026 at 10,000 shares worth $62.4K. The position accounts for ﹤0.01% of the portfolio, ranked #257.

Sprott Inc first reported a position in MRVI in Q3 2025 and has held it in 4 quarters since. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

Sprott Inc held 10,000 shares of Maravai LifeSciences worth $62.4K as of Q2 2026.
Sprott Inc left its Maravai LifeSciences share count unchanged in Q2 2026.
Maravai LifeSciences made up ﹤0.01% of Sprott Inc's portfolio in Q2 2026, its #257 holding.
Sprott Inc first reported a position in Maravai LifeSciences in Q3 2025 and has held it in 4 quarters since.
178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Sprott Inc's 13F filing for Q2 2026, filed 28 Jul 2026.